Ha habido 50 transacciones internas recientes registradas para Structure Therapeutics Inc. (GPCR), incluyendo 28 compras y 22 ventas. El total de compras internas fue valorado en $22.67M y el total de ventas internas en $3.19M.
Internos destacados con actividad reciente incluyen Stevens Raymond C, Hall Ashley, Yoon Jun. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — GPCR
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2026-03-19 |
Stevens Raymond C |
Chief Executive Officer |
Concesión de RSU |
322,230 |
$16.82 |
$5.42M |
322,230 |
| 2026-03-19 |
Hall Ashley |
Chief Development Officer |
Concesión de RSU |
59,073 |
$16.82 |
$993.61K |
59,073 |
| 2026-03-19 |
Yoon Jun |
Chief Financial Officer |
Concesión de RSU |
128,892 |
$16.82 |
$2.17M |
128,892 |
| 2026-03-19 |
Lin Xichen |
Chief Scientific Officer |
Concesión de RSU |
53,703 |
$16.82 |
$903.28K |
53,703 |
| 2026-03-19 |
Ma Yingli |
Chief Technology Officer |
Concesión de RSU |
40,278 |
$16.82 |
$677.48K |
40,278 |
| 2026-03-19 |
Coll Crespo Blas |
Chief Medical Officer |
Concesión de RSU |
93,984 |
$16.82 |
$1.58M |
93,984 |
| 2026-03-03 |
Stevens Raymond C |
Chief Executive Officer |
Retención Fiscal de RSU |
53,454 |
$20.99 |
$1.12M |
1,141,376 |
| 2026-03-03 |
Hall Ashley |
Chief Development Officer |
Retención Fiscal de RSU |
4,836 |
$20.99 |
$101.51K |
107,481 |
| 2026-03-03 |
Yoon Jun |
Chief Financial Officer |
Retención Fiscal de RSU |
22,305 |
$20.99 |
$468.18K |
1,297,571 |
| 2026-03-03 |
Lin Xichen |
Chief Scientific Officer |
Retención Fiscal de RSU |
18,735 |
$20.99 |
$393.25K |
185,592 |
| 2026-03-03 |
Ma Yingli |
Chief Technology Officer |
Retención Fiscal de RSU |
11,313 |
$20.99 |
$237.46K |
107,391 |
| 2026-03-03 |
Coll Crespo Blas |
Chief Medical Officer |
Retención Fiscal de RSU |
11,826 |
$20.99 |
$248.23K |
204,981 |
| 2026-01-15 |
Fmr Llc |
10 Percent Owner, Other: See Remark 1 |
Venta Informativa |
20 |
- |
- |
4,103 |
| 2025-12-08 |
Fmr Llc |
10 Percent Owner, Other: See Remark 1 |
Venta Informativa |
15,535 |
- |
- |
- |
| 2025-11-20 |
Stevens Raymond C |
Chief Executive Officer |
Concesión de RSU |
824 |
- |
- |
1,824 |
| 2025-11-20 |
Hall Ashley |
Chief Development Officer |
Concesión de RSU |
237 |
- |
- |
462 |
| 2025-09-18 |
Hall Ashley |
Chief Development Officer |
Retención Fiscal de RSU |
6,021 |
$7.74 |
$46.62K |
112,317 |
| 2025-09-18 |
Coll Crespo Blas |
Chief Medical Officer |
Retención Fiscal de RSU |
8,106 |
$7.74 |
$62.77K |
216,807 |
| 2025-07-30 |
Fmr Llc |
10 Percent Owner, Other: See Remark 1 |
Venta Informativa |
26,310 |
- |
- |
1,515,558 |
| 2025-07-01 |
Lin Xichen |
Chief Scientific Officer |
Retención Fiscal de RSU |
12,846 |
$6.84 |
$87.82K |
204,327 |
| 2025-07-01 |
Ma Yingli |
Chief Technology Officer |
Retención Fiscal de RSU |
4,470 |
$6.84 |
$30.56K |
118,704 |
| 2025-07-01 |
Stevens Raymond C |
Chief Executive Officer |
Retención Fiscal de RSU |
16,050 |
$6.84 |
$109.73K |
1,194,830 |
| 2025-07-01 |
Yoon Jun |
Chief Financial Officer |
Retención Fiscal de RSU |
7,089 |
$6.84 |
$48.46K |
1,319,876 |
| 2025-07-01 |
Lin Xichen |
Chief Scientific Officer |
Concesión de RSU |
57,078 |
- |
- |
217,173 |
| 2025-07-01 |
Ma Yingli |
Chief Technology Officer |
Concesión de RSU |
24,459 |
- |
- |
123,174 |
| 2025-07-01 |
Coll Crespo Blas |
Chief Medical Officer |
Retención Fiscal de RSU |
1,434 |
$6.84 |
$9.8K |
224,913 |
| 2025-06-23 |
Love Ted W |
Director |
Concesión de RSU |
51,804 |
$7.37 |
$381.8K |
51,804 |
| 2025-06-23 |
Dobmeier Eric |
Director |
Concesión de RSU |
51,804 |
$7.37 |
$381.8K |
51,804 |
| 2025-06-23 |
Welch Daniel G |
Director |
Concesión de RSU |
51,804 |
$7.37 |
$381.8K |
51,804 |
| 2025-06-23 |
Tetlow Sharon |
Director |
Concesión de RSU |
51,804 |
$7.37 |
$381.8K |
51,804 |
| 2025-06-23 |
Russell Angus C. |
Director |
Concesión de RSU |
42,833 |
$7.37 |
$315.68K |
42,833 |
| 2025-06-23 |
Waldstreicher Joanne |
Director |
Concesión de RSU |
51,804 |
$7.37 |
$381.8K |
51,804 |
| 2025-05-21 |
Stevens Raymond C |
Chief Executive Officer |
Concesión de RSU |
1,000 |
- |
- |
1,000 |
| 2025-05-21 |
Yoon Jun |
Chief Financial Officer |
Concesión de RSU |
831 |
- |
- |
2,946 |
| 2025-05-21 |
Coll Crespo Blas |
Chief Medical Officer |
Concesión de RSU |
429 |
- |
- |
1,157 |
| 2025-05-20 |
Hall Ashley |
Chief Development Officer |
Concesión de RSU |
225 |
- |
- |
225 |
| 2025-03-15 |
Stevens Raymond C |
Chief Executive Officer |
Concesión de RSU |
826,890 |
$7.02 |
$5.8M |
826,890 |
| 2025-03-15 |
Hall Ashley |
Chief Development Officer |
Concesión de RSU |
51,048 |
- |
- |
118,338 |
| 2025-03-15 |
Yoon Jun |
Chief Financial Officer |
Concesión de RSU |
413,445 |
$7.02 |
$2.9M |
413,445 |
| 2025-03-15 |
Lin Xichen |
Chief Scientific Officer |
Concesión de RSU |
80,829 |
- |
- |
166,536 |
| 2025-03-15 |
Ma Yingli |
Chief Technology Officer |
Concesión de RSU |
63,810 |
- |
- |
100,539 |
| 2025-03-15 |
Coll Crespo Blas |
Chief Medical Officer |
Concesión de RSU |
116,988 |
- |
- |
219,588 |
| 2025-03-01 |
Stevens Raymond C |
Chief Executive Officer |
Retención Fiscal de RSU |
12,495 |
$7.92 |
$98.92K |
1,121,183 |
| 2025-03-01 |
Yoon Jun |
Chief Financial Officer |
Retención Fiscal de RSU |
5,940 |
$7.92 |
$47.02K |
1,287,359 |
| 2025-03-01 |
Lin Xichen |
Chief Scientific Officer |
Retención Fiscal de RSU |
6,441 |
$7.92 |
$50.99K |
160,095 |
| 2025-03-01 |
Ma Yingli |
Chief Technology Officer |
Retención Fiscal de RSU |
1,824 |
$7.92 |
$14.44K |
98,715 |
| 2025-03-01 |
Coll Crespo Blas |
Chief Medical Officer |
Retención Fiscal de RSU |
1,233 |
$7.92 |
$9.76K |
218,355 |
| 2025-02-06 |
Fmr Llc |
10 Percent Owner, Other: See Remark 1 |
Venta Informativa |
41 |
- |
- |
- |
| 2024-11-20 |
Yoon Jun |
Chief Financial Officer |
Concesión de RSU |
821 |
- |
- |
2,115 |
| 2024-11-20 |
Coll Crespo Blas |
Chief Medical Officer |
Concesión de RSU |
363 |
- |
- |
728 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
